Recent Articles from Business Wire

Association of Medical Device Reprocessors issued the following statement:

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical-stage biopharmaceutical company focused on rare respiratory diseases, today announced new data in two poster presentations at the ATS International Conference 2025. Data presented were from the Phase 3 IMPALA-2 clinical trial of molgramostim in aPAP and demonstrated that molgramostim reduces surfactant burden and improves health-related quality of life outcomes in patients with aPAP.

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Krispy Kreme, Inc. (“Krispy Kreme” or the “Company”) (NASDAQ: DNUT) securities between February 25, 2025 and May 7, 2025, inclusive (the “Class Period”). Krispy Kreme investors have until July 15, 2025 to file a lead plaintiff motion.

Robbins Geller Rudman & Dowd LLP announces that the Elevance Health class action lawsuit – captioned Miller v. Elevance Health, Inc., No. 25-cv-00923 (S.D. Ind.) – seeks to represent purchasers of Elevance Health, Inc. (NYSE: ELV) common stock and charges Elevance Health as well as certain of Elevance Health’s executives with violations of the Securities Exchange Act of 1934.

IMVARIA Inc., a health tech company pioneering AI-driven digital biomarker solutions, today reported results from multi-site clinical experiences with IMVARIA’s diagnostic referral service, where pulmonologists send cases for AI-supported diagnostic evaluation of suspected Interstitial Lung Disease (ILD) and Idiopathic Pulmonary Fibrosis (IPF). Built by medical doctors with software engineering expertise, Fibresolve is the first ever FDA-authorized AI adjunctive diagnostic service of any type in lung fibrosis. Clinical data from use around the U.S. will be presented by pulmonary experts from Harvard’s Mass General Hospital at ATS 2025 International Conference, focusing on respiratory diseases, held on May 16-21, 2025 in San Francisco.

Capital One Financial Corporation (NYSE: COF) today announced that it has completed its acquisition of Discover Financial Services.

U-Haul® has made 24 Company stores across three states available to help storm victims with 30 days of free self-storage and U-Box® container usage after a powerful weather system spawned a number of deadly tornadoes on Friday.

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers and acquirers of Sana Biotechnology, Inc. (NASDAQ: SANA) securities between March 17, 2023 and November 17, 2024. Sana is a biotechnology company.

Clover, the world's smartest point-of-sale solution, under parent company, Fiserv, today announced the launch of Clover Hospitality by BentoBox at the 2025 National Restaurant Association (NRA) Show in Chicago, with a bold commitment to the industry and new tagline, There’s a Clover for Every Restaurant. The solution, complete with new-to-market features designed to enhance the guest experience, marks an exciting step forward as Clover – already serving more than 125,000 restaurants – expands its offerings to better serve the hospitality industry.

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of Zynex, Inc. (NASDAQ: ZYXI) between March 13, 2023 and March 11, 2025. Zynex is a medical device manufacturer.

Be Biopharma, Inc. (“Be Bio”), a clinical-stage company pioneering the discovery and development of engineered B Cell Medicines (BCMs), today presented results from new preclinical research demonstrating a single administration of BE-102, a BCM for the potential treatment for Hypophosphatasia (HPP), produces continuous levels of active ALP long-term in vivo. The findings will be presented during an oral presentation at the American Society of Gene & Cell Therapy (ASGCT) 28th Annual Meeting on Saturday, May 17, at 10:45 AM CT.

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today presented the most contemporary analysis of the HELIOS-B Phase 3 study of vutrisiran for the treatment of ATTR amyloidosis with cardiomyopathy (ATTR-CM) as a late-breaking abstract at the Heart Failure 2025 Congress, a scientific congress of the European Society of Cardiology, taking place May 17-20 in Belgrade, Serbia. The results demonstrate that vutrisiran, which rapidly knocks down transthyretin, reduces key cardiovascular (CV) events such as CV hospitalizations, and heart failure (HF) hospitalizations. Additionally, in the analysis, urgent HF visits were reduced by 46% (95% CI: 0.30, 0.98; p = 0.041) in the overall population during the double-blind period, compared to placebo. These CV events often precede all-cause mortality (ACM) and are key indicators of disease progression.

Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today successfully launched its third mission for Japanese customer, Institute for Q-shu Pioneers of Space, Inc. (iQPS).

Fujirebio today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio in-vitro diagnostic (IVD) test for the assessment of amyloid pathology in patients being evaluated for Alzheimer’s disease and other causes of cognitive decline. The test, which was granted Breakthrough Device Designation by the FDA, is the first FDA cleared blood-based IVD test in the U.S. to aid to identify patients with amyloid pathology associated with Alzheimer’s Disease (AD).

The entire Edison International, Southern California Edison and Trio community is deeply saddened to learn of the passing of John Bryson, who served as Edison International’s chairman and CEO from 1990 to 2008. John passed away Tuesday, May 13 at age 81. He was a groundbreaking leader whose remarkable career ranged from a founding role in the environmental movement to public service as the U.S. Secretary of Commerce.

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of NV5 Global, Inc. (NasdaqGS: NVEE) to Acuren Corporation (NYSE: TIC). Under the terms of the proposed transaction, NV5 shareholders will receive approximately $23.00 per share consisting of $10.00 in cash and an estimated $13.00 in shares of Acuren, subject to adjustment. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Charter Communications, Inc. (NasdaqGS: CHTR) and Cox Communications. Upon closing of the proposed transaction, Cox Enterprises will own approximately 23% of the combined entity's fully diluted shares outstanding, on an as-converted, as-exchanged basis, and pro forma for the closing of the Liberty Broadband merger. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger is fair to Charter shareholders.

Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with losses in excess of $100,000 that they have until July 15, 2025 to file lead plaintiff applications in a securities class action lawsuit against Iovance Biotherapeutics, Inc. (“Iovance” or the “Company”) (NasdaqGM: IOVA), if they purchased the Company’s securities between May 9, 2024 and May 8, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, announced the appointment of James Huang and Nachi Subramanian to its Board of Directors, effective following the completion the Company’s previously announced $16 million offering that was announced on May 15, 2025. The offering closed on May 16, 2025.

Strategic Storage Trust VI, Inc. (“SST VI”) announced operating results for the three months ended March 31, 2025.

The Port Commission of the Port of Houston Authority will hold its Regular Monthly Meeting on Tuesday, May 20, 2025, beginning at 9:15 a.m. in the boardroom of the Port Houston Executive Office Building, located at 111 East Loop North, Houston, TX 77029.

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of SelectQuote, Inc. (NYSE: SLQT) resulting from allegations that SelectQuote may have issued materially misleading business information to the investing public.

The Law Offices of Frank R. Cruz announces that it has filed a class action lawsuit in the United States District Court for the Western District of North Carolina, captioned Cameron v. Krispy Kreme, Inc., et al., Case No. 25-cv-332, on behalf of persons and entities that purchased or otherwise acquired Krispy Kreme, Inc. (“Krispy Kreme” or the “Company”) (NASDAQ: DNUT) securities between February 25, 2025 and May 7, 2025, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Capricor Therapeutics, Inc. (“Capricor” or “the Company”) (NASDAQ: CAPR) for violations of the securities laws.

The Law Offices of Frank R. Cruz announces an investigation of UroGen Pharma Ltd. (“UroGen” or the “Company”) (NASDAQ: URGN) on behalf of investors concerning the Company’s possible violations of federal securities laws.

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of GoHealth, Inc. (NASDAQ: GOCO) resulting from allegations that GoHealth may have issued materially misleading business information to the investing public.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Krispy Kreme, Inc. (“Krispy Kreme” or “the Company”) (NASDAQ: DNUT) for violations of the securities laws.

KBRA assigns a preliminary rating of "BBB” with Stable Outlook to surplus notes (“Notes”) to be issued by Clear Blue Specialty Insurance Company (CBSIC) (KBRA Insurance Financial Strength Rating: A-/Stable). As surplus notes, the Notes are deeply subordinated and payments thereon are subject to the prior approval of the Texas Department of Insurance. If any payments are not approved, the payment will be extended until approval is given. Interest will continue to accrue on any unpaid principal but interest will not accrue on unpaid interest. The surplus notes are being issued to support growth in the company’s business.

Renatus Tactical Acquisition Corp I (Nasdaq: RTACU) (the “Company”) today announced the closing of its upsized initial public offering of 24,150,000 units at $10.00 per unit, including 3,150,000 units issued pursuant to the full exercise of the underwriters' over-allotment option. The offering was priced at $10.00 per unit, resulting in gross proceeds of $241,500,000.

IFF (NYSE: IFF) announced today the Total Consideration (as defined below) payable in connection with its previously announced tender offers to purchase for cash: (i) up to $1,100,000,000 aggregate purchase price, excluding accrued and unpaid interest (the “Amended Pool 1 Maximum Amount”), of its 1.230% Senior Notes due 2025 (the “2025 Notes”), 1.832% Senior Notes due 2027 (the “2027 Notes”), 4.450% Senior Notes due 2028 (the “2028 Notes”) and 2.300% Senior Notes due 2030 (the “2030 Notes” and collectively with the 2025 Notes, the 2027 Notes and the 2028 Notes, the “Pool 1 Notes”) and (ii) up to $900,000,000 aggregate purchase price, excluding accrued and unpaid interest (the “Amended Pool 2 Maximum Amount” and, together with the Amended Pool 1 Maximum Amount, the “Amended Maximum Amounts”), of its 3.268% Senior Notes due 2040 (the “2040 Notes”), 4.375% Senior Notes due 2047 (the “2047 Notes”), 5.000% Senior Notes due 2048 (the “2048 Notes”) and 3.468% Senior Notes due 2050 (the “2050 Notes” and collectively with the 2040 Notes, the 2047 Notes and the 2048 Notes, the “Pool 2 Notes” and, together with the Pool 1 Notes, the “Notes”), subject to prioritized acceptance levels listed in the table below (“Acceptance Priority Levels”), Series Tender Caps (as defined below), if applicable, and the terms and conditions of the tender offers.

Leeward Renewable Energy Operations, LLC (“LREO”) today announced that it, as noted during its investor call held May 13, 2025, has updated its key operating and financial results for Year End 2024 and has posted the update to its secure investor relations site.

BlackRock Core Bond Trust (NYSE: BHK) (the "Fund") today announced that its Board of Trustees (the "Board") has approved the terms of the issuance of transferable rights ("Rights") to the holders of the Fund's common shares of beneficial interest (par value $0.001 per share) ("Shares") as of May 27, 2025 (the "Record Date"). Holders of Rights will be entitled to subscribe for additional Shares (the "Offer") at a discount to the market price of the Shares.

The Missouri Public Service Commission (MoPSC) approved new water and wastewater rates for Missouri American Water in a rate order on May 7, 2025.

Mayville Engineering Company (NYSE: MEC) (the “Company” or “MEC”), a leading value-added provider of design, prototyping and manufacturing solutions serving diverse end-markets, today announced that one of its manufacturing facilities in Mayville, Wisconsin sustained limited damage from a tornado on Thursday, May 15, 2025. All onsite employees are safe and no injuries were reported. The Company expects a minimal impact to its business and anticipates the facility will resume normal operations by early next week.

Birks Group Inc. (the “Company”) (NYSE American LLC: BGI), announced today that the NYSE American LLC (“NYSE American”) has accepted the Company’s plan of compliance for continued listing on NYSE American.

Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) announced today that its board of trustees has declared a distribution of CDN $0.2833 per unit for the month of May 2025. The distribution will be paid by Granite on June 16, 2025 to unitholders of record at the close of trading on Friday, May 30, 2025.

Syncora Guarantee Inc. (“Syncora Guarantee”) today announced that certain financial information of Syncora Guarantee has been made available on Syncora Guarantee's website (www.syncoraguarantee.com). The information posted is Syncora Guarantee’s Statutory Basis Financial Statements as of March 31, 2025.

Shift4 Payments, Inc. (NYSE: FOUR), a leader in integrated payments and commerce technology, today announced the completion of the previously announced offering of €680 million aggregate principal amount of 5.500% senior notes due 2033 (the “Euro Notes”) and tack-on offering of $550 million aggregate principal amount of 6.750% senior notes due 2032 (the “New 2032 Notes” and, together with the Euro Notes, the “Notes”) by Shift4 Payments, LLC (“Shift4”) and Shift4 Payments Finance Sub, Inc. (together with Shift4, the “Issuers”), subsidiaries of Shift4 Payments, Inc. The Notes are guaranteed, jointly and severally, on a senior unsecured basis, by certain of Shift4’s subsidiaries. The New 2032 Notes were issued as additional securities under an Indenture, dated August 15, 2024 (as supplemented from time to time, the “2032 Notes Indenture”), pursuant to which the Issuers issued $1,100,000,000 in aggregate principal amount of their 6.750% senior notes due 2032 (the “Existing 2032 Notes”) on August 15, 2024. The New 2032 Notes and the Existing 2032 Notes are treated as a single class of debt securities under the 2032 Notes Indenture, and the New 2032 Notes have identical terms to the Existing 2032 Notes, other than with respect to the issue date and issue price.

The European Equity Fund, Inc. (NYSE: EEA) and The New Germany Fund, Inc. (NYSE: GF) (each, a “Fund,” and collectively, the “Funds”) each announced today that its Board of Directors declared the distributions set forth below. GF’s and EEA’s total distributions will be paid in cash to the stockholders of record as of May 27, 2025.

DWS Municipal Income Trust (NYSE: KTF) (the “Fund”) announced that the Annual Meeting of Shareholders for the Fund will be held on September 19, 2025 at the offices of DWS Investment Management Americas, Inc., 100 Summer Street, Boston, Massachusetts. Holders of record of common shares and preferred shares of the Fund at the close of business on August 1, 2025 will be entitled to vote at the Annual Meeting and any adjournments or postponements thereof.

Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of up to 94,050 shares of common stock. Awards were made to nine new employees of the Company. The awards were granted as an inducement material to the new employees becoming employees of the Company in accordance with Nasdaq Listing Rule 5635(c)(4) and have been approved by the Company’s Compensation Committee. The inducement awards were granted on May 14, 2025. The options have a ten (10) year term and an exercise price of $22.75 per share, the closing price per share of the Company’s common stock as reported by Nasdaq on May 14, 2025. The options were granted from a pool of equity incentives reserved by the Compensation Committee on January 22, 2025 for issuance as inducements to new employees in accordance with Nasdaq Listing Rule 5635(c)(4).

As previously announced on May 14, 2025, Carlyle (NASDAQ: CG) (“Carlyle”), SK Capital Partners, LP (“SK Capital”) and bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird”), have amended their definitive agreement pursuant to which Carlyle and SK Capital will purchase all of the outstanding shares of bluebird. The parties have issued the following updated instructions for stockholders to tender their shares into the offer.

NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in therapeutic devices, today announced the closing of its previously announced underwritten public offering of 400,000 shares of the Company’s Series G Convertible Preferred Stock (“Preferred Stock”), with a par value $0.001 per share and a stated value equal to $25, and Warrants to purchase up to 4,901,982 shares of common stock, par value $0.001 per share (the “Common Stock”) of the Company at an exercise price of $2.04 per share (the “Warrants”). The combined public offering price of each share of Preferred Stock together with an accompanying Warrant is $25.00. The Warrants have a term of five years from the initial issuance date and are exercisable immediately upon issuance. The holders of the Preferred Stock are entitled to receive cumulative dividends at the rate per share of 9% per annum of the stated value per share until the fifth anniversary of the date of issuance of the Preferred Stock, which such dividends may be paid, at the Company’s option, in up to an aggregate of 2,205,883 shares of Common Stock.

Today, Southern California Edison submitted its 2026-2028 Wildfire Mitigation Plan (WMP) to California’s Office of Energy Infrastructure Safety. The plan builds on ongoing efforts to address immediate and long-term wildfire risks in response to evolving community needs and extreme weather events.

Helmerich & Payne, Inc. (NYSE: HP) announced today it has engaged Eastdil Secured, a national commercial brokerage firm, to explore future options for Utica Square.

The Board of Directors of Albany International Corp. (NYSE: AIN) today declared a quarterly dividend of $0.27 per share on the Company’s Class A Common Stock.

Scholar Rock (NASDAQ: SRRK; the “Company”), a late-stage biopharmaceutical company focused on developing and commercializing apitegromab for patients with spinal muscular atrophy (SMA) and other severe and debilitating neuromuscular diseases, today announced that the company granted inducement equity awards covering an aggregate of 105,700 shares of its common stock to 14 newly hired employees, consisting of inducement stock options to purchase an aggregate of 60,400 shares of common stock and inducement restricted stock units, covering an aggregate of 45,300 shares of its common stock.

DTF Tax-Free Income 2028 Term Fund Inc. (NYSE: DTF) (the “Fund”), a closed-end fund advised by Duff & Phelps Investment Management Co., today announced that Phillip Hooks, CFA, will step down as portfolio manager of the Fund effective May 16, 2025.

AM Best has downgraded the Financial Strength Rating to B (Fair) from B+ (Good) and the Long-Term Issuer Credit Rating to “bb+” (Fair) from “bbb-” (Good) of Life Insurance Company of Louisiana (LICOL) (Shreveport, LA). The outlooks of these Credit Ratings (ratings) is stable.

Rayonier Inc. (NYSE:RYN) announced today that the Company’s board of directors has declared a second quarter cash dividend of $0.2725 per common share. The dividend is payable on June 30, 2025, to shareholders of record on June 16, 2025.

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today announced the successful completion of a $250 million strategic investment by funds affiliated with KKR, a leading global investment firm. Upon the closing of this transaction, KKR has become the holder of approximately 12% of the common shares of Henry Schein.

Grove Collaborative Holdings, Inc. (NYSE: GROV) (“Grove” or “the Company”), reports that, on May 15, 2025, it received written notice (the “NYSE Notice”) from the New York Stock Exchange (“NYSE”) of non-compliance with Section 802.01B of the NYSE Listed Company Manual (the “NYSE Manual”), which requires an average global market capitalization of not less than $50 million over a consecutive 30 trading-day period and stockholders’ equity of not less than $50 million.

Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Western District of North Carolina, captioned Cameron v. Krispy Kreme, Inc., et al., Case No. 25-cv-332, on behalf of persons and entities that purchased or otherwise acquired Krispy Kreme, Inc. (“Krispy Kreme” or the “Company”) (NASDAQ: DNUT) securities between February 25, 2025 and May 7, 2025, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).

Paychex, Inc. (Nasdaq: PAYX), an industry-leading human capital management (HCM) company, today announced that the company’s Founder, B. Thomas Golisano, has decided to step down from his role as a member of the Paychex Board of Directors effective after the Board’s July, 2025 meeting.

Carlisle Companies Incorporated (NYSE:CSL) today announced the appointment of Christopher B. Gaskill as Vice President & General Counsel for the Company. In conjunction with this appointment, Scott C. Selbach will transition to a new role as Executive Vice President, Government Relations for the Company. Mr. Selbach will also remain Secretary of the Company. Both Mr. Gaskill and Mr. Selbach will report to Chris Koch, Carlisle’s Chair, President & Chief Executive Officer.

Savers Value Village, Inc. (the “Company”) (NYSE: SVV), the largest for-profit thrift operator in the United States (“U.S.”) and Canada for value priced pre-owned clothing, accessories and household goods, today announced the closing of the previously announced secondary offering (the “Offering”) of 15,000,000 shares of its common stock, par value $0.000001, of the Company (the “Common Stock”) offered by certain Ares Management Private Equity and Opportunistic Credit funds and accounts (the “Ares Selling Stockholders”) and the chief executive officer of the Company (the “Management Selling Stockholder” and, together with the Ares Selling Stockholders, the “Selling Stockholders”).

Kentucky American Water filed a request today with the Kentucky Public Service Commission (PSC) for new rates, reflecting more than $212 million in system investments. The request reinforces the company’s commitment to replacing aging infrastructure and continuing to provide safe, clean, reliable and affordable service in compliance with environmental regulations for the benefit of customers.

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant in May of non-qualified stock options to purchase an aggregate of 12,706 shares of Evolus and an aggregate of 40,576 restricted stock units (RSUs) of the company’s common stock to 16 newly hired non-executive employees of the company. The awards were approved by the compensation committee of the company’s board of directors under the Evolus 2023 Inducement Incentive Plan, with a grant date of May 12, 2025 and vesting commencement date of May 7, 2025, as an inducement material to the new employees entering into employment with Evolus in accordance with Nasdaq Listing Rule 5635(c)(4).

Hyosung America, the North American leader in ATM and payments technology, has promoted Chris King to Chief Revenue Officer. In his new role, King is charged with accelerating the company's growth in the financial and retail technology sectors. King, who previously served as senior vice president of sales, will now oversee all revenue operations through direct sales, channel partnerships, marketing and strategic account development.

The U-Haul® facility at 889 State Hwy. 76 has closed most services and converted to a remote self-storage site. The transition was completed on May 13.

AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “a-” (Excellent) of Austral Resseguradora S.A. (Austral Re) and Austral Seguradora S.A. Concurrently, AM Best has affirmed the Long-Term ICR of “bbb-” (Good) of Austral Participações S.A. (Austral). The outlook of these Credit Ratings (ratings) is stable. All companies are domiciled in Brazil and collectively referred to as Austral.

KBRA assigns preliminary ratings to notes issued RFS Asset Securitization V LLC (the “Issuer”). RFS Asset Securitization V LLC will issue five classes of Series 2025-1 Notes totaling $130 million initially.

Empire State Realty Trust, Inc. (NYSE: ESRT) (the “Company”), today announced that its Board of Directors has declared a dividend of $0.035 per share for the second quarter of 2025, payable to holders of the Company’s Class A common stock and Class B common stock and to holders of Empire State Realty OP, L.P.’s (“ESRO”) Series ES, Series 250 and Series 60 operating partnership units (NYSE Arca: ESBA, FISK and OGCP, respectively) and Series PR operating partnership units.

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Endo, Inc. (OTC: NDOI) and Mallinckrodt plc. Under the terms of the proposed transaction, Endo shareholders will own 49.9% of the combined company. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger is fair to Endo shareholders.

Liberate Bio, Inc., a biotechnology company developing medicines which efficiently and selectively deliver payloads to immune cells while bypassing the live, announced an oral presentation by Melissa Deck - Director of Platform, demonstrating the success of Liberate’s RAPTOR™ screening platform and NHP data for the company’s first lead candidates at the Oligonucleotide and Peptide Therapeutics 2025 (TIDES) being held May 19th-22nd, 2025 in San Diego, California.

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Bridge Investment Group Holdings Inc. (“Bridge” or the “Company”) (NYSE: BRDG) to Apollo Global Management, Inc. (NYSE: APO). Under the terms of the proposed transaction, Bridge shareholders and Bridge OpCo unitholders will receive, at closing, 0.07081 shares of Apollo stock for each share of Bridge Class A common stock and each Bridge OpCo Class A common unit, respectively. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

Trex Company, Inc. (NYSE:TREX), the world’s largest manufacturer of wood-alternative decking and railing and a leader in high-performance, low-maintenance outdoor living products, today announced its participation in the following investor conference:

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Dun & Bradstreet Holdings, Inc. (NYSE: DNB) to Clearlake Capital Group, L.P. Under the terms of the proposed transaction, shareholders of Dun & Bradstreet will receive $9.15 in cash for each share of Dun & Bradstreet that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Redwire Corporation (NYSE: RDW) and Edge Autonomy. Pursuant to the terms of the agreement, Redwire will pay the purchase price for the acquisition of Edge Autonomy in a combination of $150 million in cash and $775 million in shares of Redwire common stock. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger is fair to Redwire minority shareholders.

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Logan Ridge Finance Corporation (NasdaqGS: LRFC) to Portman Ridge Finance Corporation (NasdaqGS: PTMN). Under the terms of the proposed transaction, shareholders of Logan Ridge will receive 1.50 newly issued shares of Portman for each share of Logan Ridge that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

Certified Financial Planner Board of Standards, Inc. (CFP Board), a nonprofit organization with more than 100,000 CFP® professionals, today announced actions taken to uphold its ethical standards, imposing sanctions on seven individuals.

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of GlycoMimetics, Inc. (NasdaqGM: GLYC) and Crescent Biopharma, Inc. Pursuant to the terms of the agreement, shareholders of GlycoMimetics will own approximately 3.1% of the combined company. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger is fair to GlycoMimetics shareholders.

BioRewards Plasma Services (“BioRewards”), a next-generation plasma collection company, has officially launched with the backing of Alpha-1 Plasma Holdings (“Alpha-1”), a premier investor in plasma collection infrastructure. With equity commitments and debt financing, BioRewards is set to deploy over $100 million in capital to open more than 20 state-of-the-art plasma collection centers across the U.S. over the next three years, with other centers in the conception stage outside the US within key nations. The company aims to redefine donor experience, enhance efficiency through cutting-edge technology, and deliver high-quality plasma materials to fractionators worldwide.

Flowserve Corp. (NYSE: FLS), a leading provider of flow control products and services for the global infrastructure markets, has released the voting results of its 2025 Annual Meeting of Shareholders and announced its quarterly cash dividend.

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the U.S. District Court for the District of Delaware ruled in favor of Acadia regarding its ‘721 formulation patent for NUPLAZID® (pimavanserin), Acadia’s drug for the treatment of Parkinson’s Disease Psychosis. In today’s order, the Court ruled in favor of Acadia on both infringement and validity arguments in its formulation patent litigation against Aurobindo Pharma Limited and other ANDA (Abbreviated New Drug Application) filers.